CIK 0001158780 · Non-accelerated filer<br>Smaller reporting company
Pluri Inc.
Sign in to watch- Ticker
- PLUR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 980351734
- Phone
- 972-74-710-7171
- Business address
- MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, Israel
- Former names
- PLURISTEM THERAPEUTICS INC, PLURISTEM LIFE SYSTEMS INC, AI SOFTWARE INC
- 4 Grant or award Director acquired 11,173 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 67,857 shares (grant or award)
- 4 Grant or award Director acquired 14,350 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 181,900 shares (grant or award)
- 4 Grant or award Director acquired 10,250 shares (grant or award)
- 4 Grant or award Director acquired 11,685 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Executive Officer acquired 25,240 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 8,413 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 355,000 shares (grant or award)
- 4 Grant or award Director acquired 44,100 shares (grant or award)
- 4 Grant or award Director acquired 39,900 shares (grant or award)
- 4 Grant or award Director acquired 38,150 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 700,000 shares (grant or award)
- 4 Grant or award Director acquired 37,100 shares (grant or award)
- 4 Grant or award Director acquired 36,750 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Executive Officer acquired 334,821 shares (grant or award)
Page 2 of 18 · 352 filings